203.05 USD
↘ 1.36 (0.67%)PRE MARKET (AS OF 04:42 AM EDT)
AstraZeneca PLC
AZNNYSE • USD
Market: OPEN
Open?$203.52
High?$203.61
Low?$202.78
Prev. Close?$204.27
Volume?10.8K
Avg. Volume?2.0M
VWAP?$203.17
Rel. Volume?0.01x
Bid / Ask
Bid?$204.26 × 1.6K
Ask?$203.05 × 200
Spread?-$1.21
Midpoint?$203.66
Valuation & Ratios
Market Cap?316.8B
Shares Out?N/A
P/E Ratio?218.32
P/B Ratio?21.33
EPS?$0.94
Dividend?0.74%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.87Weak
Quick Ratio?0.72Weak
Cash Ratio?0.33Low
Debt/Equity?1.77High
ValuationRICHLY VALUED
Score33/100
P/E?218.3PRICEY▾
P/B?21.33HIGH▾
P/S?17.49HIGH▾
P/FCF?349.3PRICEY▾
EV/EBITDA?78.6HIGH▾
EV/Sales?18.66HIGH▾
Returns & Efficiency
ROE?9.8%FAIR▾
ROA?2.3%WEAK▾
Cash Flow & Enterprise
FCF?$907.0M
Enterprise Value?$338.1B
Related Companies
Loading...
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.